Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history

S Larnaudie, N Guiso, C Baptiste, C Desaint… - Human …, 2010 - Taylor & Francis
This study was to assess the humoral immune response induced by a vaccination schedule
routinely used in France in 18-50 year old adults with unknown vaccination history. In this …

Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus …

R Dominicus, F Galtier, P Richard, M Baudin - Vaccine, 2014 - Elsevier
Introduction The immunogenicity and safety of one dose of Tdap-IPV (tetanus, diphtheria,
acellular pertussis and inactivated poliomyelitis vaccine) and two doses of Td-IPV (tetanus …

[PDF][PDF] Long-term immunogenicity assessment of a DTaP-IPV//PRP-T vaccine given at 2, 4, 6 and 18-19 months of age, and immunogenicity and safety of a DTaP-IPV …

C Pancharoen, T Chotpitayasunondh… - … Asian Journal of …, 2012 - academia.edu
Booster vaccination of infants aims to further reduce the burden of childhood infectious
diseases. This study assessed the antibody persistence induced by a primary series …

Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria …

H Theeten, H Rümke, FJP Hoppener… - … medical research and …, 2007 - Taylor & Francis
Objective: To evaluate immunogenicity and reactogenicity of primary vaccination with
reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) or dTpa-inactivated …

The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV)

P Laroche, M Barrand, SC Wood, K Van Hasbrouck… - Infection, 1999 - Springer
In view of the continuing risk of contracting tetanus, diphtheria and poliomyelitis, and the well-
documented decline in immunity with time, the need for booster vaccinations is substantial …

Diphtheria, tetanus and poliovirus antibody persistence 5 years after vaccination of pre-schoolers with two different diphtheria, tetanus and inactivated poliomyelitis …

V Gajdos, E Vidor, P Richard, C Tran, C Sadorge - Vaccine, 2015 - Elsevier
Introduction This follow-up study assessed the 5-year persistence of vaccine-induced
antibodies (Td-IPV or DT-IPV) and the immune response to a booster dose of DTaP-IPV …

Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax®) administered …

U Zimmermann, G Gavazzi, P Richard, C Eymin… - Vaccine, 2013 - Elsevier
BACKGROUND: Annual influenza vaccination provides an opportunity to administer a
booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine …

Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial

J Beytout, O Launay, N Guiso, A Fiquet, M Baudin… - Human …, 2009 - Taylor & Francis
Background: In France, the only vaccines available for use as a pertussis booster in adults
are combined vaccines containing adsorbed tetanus, diphtheria (adult formulation), acellular …

[HTML][HTML] A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria …

R Marlow, S Kuriyakose, N Mesaros, HH Han… - Vaccine, 2018 - Elsevier
Aim To evaluate the immunogenicity and safety of a reduced antigen diphtheria-tetanus-
acellular pertussis-inactivated poliovirus (dTap-IPV B) vaccine (Boostrix-IPV, GSK) as a pre …

[HTML][HTML] Evaluation of adult dTPaP vaccination coverage in France: experience in Lyon city, 2010–2011

D Baratin, C Del Signore, J Thierry, E Caulin… - BMC Public Health, 2012 - Springer
Background Compliance with official recommendations can be assessed by evaluating
vaccination coverage (VC) in populations. The main objective of our study was to assess VC …